Nutritional status is often impaired among patients with liver cirrhosis, and this results in malnutrition in more than 50% of the cases. 1 The main feature of malnutrition comprises loss of muscle mass and altered functionality, i.e. sarcopenia. 2 It has been reported that about 40% of patients with liver cirrhosis are sarcopenic and the percentage of such patients increases along with the severity of the disease. 3 Studies have shown that sarcopenic cirrhotic patients are at higher risk of developing complications (refractory ascites, hepatorenal syndrome, spontaneous bacterial peritonitis or hepatic encephalopathy) and death. 3-6 The current "gold standard" in evaluating sarcopenia is skeletal muscle mass estimation by means of computed tomography (CT) scans or magnetic resonance imaging (MRI). The "skeletal muscle index", which takes into account all skeletal muscle groups at the level of the L3-L4 vertebrae, 3,6,7 the "psoas muscle thickness by height" 5,7 or the "psoas muscle index" can be measured. 8-10 However, CT scans and MRI are of limited use as screening tools, as they may be expensive, time consuming (MRI) and prone to artifacts in patients with ascites (MRI) 11 or irradiating (CT scans). 12 Surrogate markers of sarcopenia include the Subjective Global Assessment (SGA) score and anthropometric measurements such as mid-arm muscle circumference (MAMC) and hand grip strength (HGS). SGA, MAMC and HGS show correlations with the skeletal muscle index in cirrhotic patients and in other populations. 13,14 The prognosis for patients with liver cirrhosis is determined using several scores. The Child-Pugh score was the first one to be proposed. 15 The model for end-stage liver disease (MELD) was implemented as a prognostic score for cirrhotic patients undergoing trans-jugular intrahepatic I MD.